COVID – Safe Guidelines for Research – Update February 2023
The Australian Catholic University continues to prioritise the health and safety of our community. The following outlines our approach to managing COVID-19 risks in research in 2023. As we move to public health recommendations rather than mandatory requirements, we seek your cooperation in following this guidance to keep our community healthy and minimise the impacts of illness throughout the conduct of your research at ACU.
The Federal Government outlines restrictions and recommendations on its COVID-19 website and information relevant to the different states is available from the Safe Work Australia site. Further guidance (from 2020) has been provided to Universities with a guide published by Universities Australia ‘Principles andProtocols for Reducing the Potential Risk of COVID-19 Transmission at Universities’.
If your research involves vulnerable groups such as Aboriginal and Torres Strait Islander People, older Australians/aged care settings, people with a disability then you should refer to The Department of Healthand Aged Care for COVID-19 requirements when working with these groups. The ACU HREC requires researchers in contact with vulnerable groups to have received three doses of COVID-19 vaccine. It is the researcher’s responsibility to ensure they are conversant with any requirements by external agencies (which may differ from state to state) for conducting research at their sites.
ACU researchers should take into consideration the following factors as to whether the research can continue or should be delayed for research activities that involve close contact.
- The overall benefits of the research continuing against the possibility of transmission of COVID-19;
- Risk management strategies;
- Whether the research is time-critical for delivering substantial benefits to patient cohorts;
- If the research activity could be delayed;
- Whether the research protocols could be changed to eliminate or reduce face-to-face interaction to 15 minutes or less;
- Whether the study involves participant groups who are at an elevated risk;
- Whether the study involves access to facilities such as aged care residences, hospitals, schools, etc. that may be subject to heightened access restrictions;
- Where face-to-face or physical interactions remain, whether all other available transmission controls (e.g. personal protection equipment, suitable hygiene practices, etc.) are in
After considering these factors, if researchers determine that the research activity will continue they should remind participants of what their participation entails (e.g., location of the research, transport to location, physical contact, etc.) and that they are free to withdraw at any time and for any reason.
Any enquiries should be directed to the ACU Human Research Ethics Committee (res.ethics@acu.edu.au)